EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Odronextamab: a bispecific antibody for follicular lymphoma

Alejandro Martín García-Sancho, Almudena Cabero-Martínez, Norma C Gutiérrez

Expert Opinion on Investigational Drugs · 03.07.2026 · 35 (7) · 489-497

DOI: 10.1080/13543784.2026.2689652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Opinion on Investigational Drugs, online erschienen am 24.06.2026. Verfasst von Alejandro Martín García-Sancho und 2 weiteren Autor:innen. Beteiligte Einrichtung: IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, University Hospital of Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Lymphoma, Follicular, Antineoplastic Agents. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificLymphoma, FollicularAntineoplastic AgentsHumansAnimalsNeoplasm Recurrence, LocalDisease ProgressionAntibodies, Monoclonal, HumanizedDrug Development

Stichwörter der Autor:innen

Bispecific antibodiesepcoritamabfollicular lymphomamosunetuzumabodronextamab

Substanzen

Antibodies, BispecificAntineoplastic AgentsAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, University Hospital of Salamanca, Salamanca, Spain.

Zitieren

APA

Martín García-Sancho, A., Cabero-Martínez, A., & Gutiérrez, N. C. (2026). Odronextamab: a bispecific antibody for follicular lymphoma. Expert Opinion on Investigational Drugs, 35(7), 489-497. https://doi.org/10.1080/13543784.2026.2689652

Vancouver

Martín García-Sancho A, Cabero-Martínez A, Gutiérrez NC. Odronextamab: a bispecific antibody for follicular lymphoma. Expert Opinion on Investigational Drugs. 2026;35(7):489-497. doi:10.1080/13543784.2026.2689652

BibTeX
@article{MartnGarcaSancho2026,
  author = {Martín García-Sancho, Alejandro and Cabero-Martínez, Almudena and Gutiérrez, Norma C},
  title = {Odronextamab: a bispecific antibody for follicular lymphoma},
  journal = {Expert Opinion on Investigational Drugs},
  year = {2026},
  volume = {35},
  number = {7},
  pages = {489--497},
  doi = {10.1080/13543784.2026.2689652}
}
Kostenlos starten →